Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax(R)) in healthy adolescents and adults

Author： Oka/Merck Varicella Vaccine Study Group   Kuter B.J.   Ngai A.   Patterson C.M.   Staehle B.O.   Cho I.   Matthews H.   Provost P.J.   White C.J.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.13, Iss.11, 1995-01, pp. : 967-972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax(R)) in children and adults

By Krah D.L.   Cho I.   Schofield T.   Ellis R.W.  

Vaccine, Vol. 15, Iss. 1, 1997-01 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX&unknown; in healthy children

By Lau Y.-L.   Vessey S.J.R.   Chan I.S.F.   Lee T.-L.   Huang L.-M.   Lee C.-Y.   Lin T.-Y.   Lee B.W.   Kwan K.   Kasim S.M.   Chan C.Y.   Kaplan K.M.   Distefano D.J.   Harmon A.L.   Golie A.   Hartzel J.   Xu J.   Li S.   Matthews H.   Sadoff J.C.   Shaw A.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2942-2949

Elsevier

Access to resources Recommend Favorite

An acellular pertussis vaccine in healthy adults: safety and immunogenicity

By Rothstein E.P.   Anderson E.L.   Decker M.D.   Poland G.A.   Reisinger K.S.   Blatter M.M.   Jacobson R.M.   Mink C.M.   Gennevois D.   Izu A.E.   Sinangil F.   Langenberg A.G.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2999-3006

Elsevier

Access to resources Recommend Favorite

Hepatitis A vaccine in healthy adults: a comparison of immunogenicity and reactogenicity between two- and three-dose regimens

By Lu M.-Y.   Chang M.-H.   Tsai K.-S.   Chen D.-S.  

Vaccine, Vol. 17, Iss. 1, 1999-01 ,pp. : 26-30

Elsevier

Access to resources Recommend Favorite

An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA(R)) in adults: safety, tolerability, and immunogenicity

By Linglof T.   van Hattum J.   Kaplan K.M.   Corrigan J.   Duval I.   Jensen E.   Kuter B.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3968-3971

Elsevier

Access to resources Recommend Favorite